Tell Us About Areas of Scientific Opportunity that Would Benefit from the Unique Research Resources of the NIH Clinical Center

The NIH Clinical Center, as the largest biomedical research hospital in the world, is a unique local, regional, and national research resource.  To ensure the Clinical Center is maximizing its potential to support the best possible science, the NIH Director is seeking input regarding needs and opportunities for inpatient clinical research resources. Respond to the request for information by November 24, 2017.

Email this to someoneTweet about this on TwitterShare on Facebook1Share on LinkedIn0Share on Google+0Pin on Pinterest0Print this page

4 thoughts on “Tell Us About Areas of Scientific Opportunity that Would Benefit from the Unique Research Resources of the NIH Clinical Center

  1. Induced Transforming Growth Factor-beta. Identifying the nutrients for the functions of growth factors and how they are initiated under what circumstances by which Amino acids.

  2. While current bio-immune targeting drugs continue to overwhelm the literature regarding the transient therapeutic successes in treating malignant melanoma, the industry as well as NCI scientific reviewers of research proposals for funding show a blatent disregard for what could be a more successful laboratory proven and possibly more effective treatment for this condition. Closed minds never change history.

    Richard A. Berjian, D.O.

  3. A scientifically administered inpatient facility that does not require short term stays is a vanishing resource. This resource demands questions that require long. – term that were otherwise impossible.
    Psychiatric diagnosis rests largely on the interview statements of patients. Due to the mandated short stays it is impossible to evaluate the outcomes of prescribed treatments or to notice serendipitous unexpected beneficial treatments Clinically it has been shown that information from close informants is useful since patients often minimize , exaggerate or distort. Nonetheless it is not standard practice to gather informant information with regard to hospitalized psychiatric patients or to objectively record their functional capacities and interpersonal interactions. Uniquely all such patients can be withdrawn from their current ineffective treatment regimen.. A focus on the recruitment of treatment refractory depressives would allow a complex scientific description of this poorly understood but socially expensive group. NIMH has the unique capacity for recruiting relatively rare but important clinical states . These carefully planned observations form the basis for evaluating planned therapeutic interventions.

  4. As a Patient Advocate, I feel that support for excellent Nutrition is lacking. MDs say there aren’t good studies. I say Nutrition does not lend itself to the ‘pharma’ model. It is NOT a single drug and the effects are long-lasting but can be studied in our excretion.

    Nutrition is not a single agent, it is time we stopped arguing about it and studied it. What about the effects of years of pesticides, artificial colors, flavors and preservatives? What is the impact over time, in combination/synergistically?

Leave a Reply

Your email address will not be published. Required fields are marked *